Sitagliptin-Based Triple FDC Achieves Greater HbA1c Reduction Than Metformin Plus Glimepiride in Indian Diabetics: Study

A new study published in the journal of Diabetes Obesity and Metabolism showed that a triple fixed-dose combination containing sitagliptin provides a larger reduction in HbA1c levels when compared to...
Read the full report on Business Medical Dialogues
Story file
- Section
- Health
- Topics
- Health alerts
- First reported by
- Business Medical Dialogues
- Reporter
- jacinthlyn sylvia
- Published
- Monday, 26 October 2026, 9:15 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Business Medical Dialogues with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.